5-FLUOROURACIL (FU) WITH THYMIDINE (TDR) - PHASE-I STUDY

被引：0
|
作者：
KIRKWOOD, JM [1 ]
FREI, E [1 ]
机构：
[1] SIDNEY FARBER CANC INST,BOSTON,MA 02115
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [31] CYTO-TOXIC AND CYTOKINETIC EFFECTS OF THYMIDINE (TDR), 5-FLUOROURACIL (FU), AND DEOXYCYTIDINE (CDR) ON HELA-CELLS IN CULTURE
    FRIED, J
    PEREZ, A
    DOBLIN, J
    MARTINS, E
    CLARKSON, B
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 279 - 279
  • [32] PHASE-I EVALUATION OF A BIOCHEMICALLY DESIGNED COMBINATION - PALA, THYMIDINE, AND 5-FU
    CASPER, ES
    MICHAELSON, RA
    KEMENY, N
    MARTIN, DS
    YOUNG, CW
    [J]. CANCER TREATMENT REPORTS, 1984, 68 (03): : 539 - 541
  • [33] PHASE II TRIAL OF SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE (PALA), THYMIDINE (TDR), AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLORECTAL-CANCER
    OCONNELL, M
    MOERTEL, C
    RUBIN, J
    HAHN, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 182 - 182
  • [34] RADIATION-THERAPY AND 5-FLUOROURACIL MODULATED BY LEUCOVORIN FOR ADENOCARCINOMA OF THE PANCREAS - A PHASE-I STUDY
    SCHIFELING, DJ
    KONSKI, AA
    HOWARD, JM
    DOBELBOWER, RR
    MERRICK, HW
    SKEEL, RT
    [J]. INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1992, 12 (03) : 239 - 243
  • [35] CONTINUOUS INFUSION 5-FLUOROURACIL WITH ESCALATING DOSES OF INTERMITTENT CISPLATIN AND ETOPOSIDE - A PHASE-I STUDY
    SAPHNER, T
    TORMEY, DC
    ALBERTINI, M
    [J]. CANCER, 1991, 68 (11) : 2359 - 2362
  • [36] PHASE-I TRIAL OF 5-FLUOROURACIL BY 24-HOUR INFUSION WEEKLY
    HAAS, NB
    HINES, JB
    HUDES, GR
    JOHNSTON, N
    OZOLS, RF
    ODWYER, PJ
    [J]. INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 181 - 185
  • [37] A PHASE-I TRIAL OF PROTRACTED 5-FLUOROURACIL INFUSION AND ORAL CALCIUM LEUCOVORIN
    HANSEN, RM
    BEATTY, PA
    QUEBBEMAN, EJ
    ANDERSON, T
    [J]. CANCER INVESTIGATION, 1993, 11 (03) : 247 - 251
  • [38] DUAL MODULATION OF 5-FLUOROURACIL USING LEUCOVORIN AND HYDROXYUREA - A PHASE-I TRIAL
    LOKICH, J
    ANDERSON, N
    BERN, M
    COCO, F
    ZIPOLI, T
    MOORE, C
    GONSALVES, L
    [J]. CANCER, 1991, 68 (04) : 744 - 746
  • [39] LEUCOVORIN INCREASES THE TOXICITY OF 5-FLUOROURACIL - PHASE-I CLINICAL PHARMACOLOGICAL TRIALS
    BRUCKNER, HW
    STORCH, JA
    HOLLAND, JF
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 192 - 192
  • [40] PHASE-I CLINICAL AND PHARMACOLOGIC STUDY OF THYMIDINE (TDR) AND CISPLATIN (DDP) IN PATIENTS WITH ADVANCED CANCER
    SCHILSKY, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 152 - 152
12345